MX343411B - Variantes de hemaglutinina y neuraminidasa de influenza. - Google Patents

Variantes de hemaglutinina y neuraminidasa de influenza.

Info

Publication number
MX343411B
MX343411B MX2013015094A MX2013015094A MX343411B MX 343411 B MX343411 B MX 343411B MX 2013015094 A MX2013015094 A MX 2013015094A MX 2013015094 A MX2013015094 A MX 2013015094A MX 343411 B MX343411 B MX 343411B
Authority
MX
Mexico
Prior art keywords
influenza hemagglutinin
neuraminidase variants
neuraminidase
variants
vaccines
Prior art date
Application number
MX2013015094A
Other languages
English (en)
Inventor
Jin Hong
Cheng Xing
Subbarao Kanta
Original Assignee
The Government Of The United States Of America Nat Inst Of Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Government Of The United States Of America Nat Inst Of Health filed Critical The Government Of The United States Of America Nat Inst Of Health
Publication of MX343411B publication Critical patent/MX343411B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a polipéptidos, polinucleótidos, virus reordenantes, composiciones inmungénicas y vacunas que comprenden variantes de hemaglutinina y neuraminidasa de influenza y el método de uso de los mismos.
MX2013015094A 2009-02-12 2011-08-11 Variantes de hemaglutinina y neuraminidasa de influenza. MX343411B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15209409P 2009-02-12 2009-02-12

Publications (1)

Publication Number Publication Date
MX343411B true MX343411B (es) 2016-11-04

Family

ID=42562246

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2011008497A MX2011008497A (es) 2009-02-12 2010-02-03 Variantes de hemaglutinina y neuraminidasa de influenza.
MX2013015094A MX343411B (es) 2009-02-12 2011-08-11 Variantes de hemaglutinina y neuraminidasa de influenza.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2011008497A MX2011008497A (es) 2009-02-12 2010-02-03 Variantes de hemaglutinina y neuraminidasa de influenza.

Country Status (11)

Country Link
US (2) US8613935B2 (es)
EP (1) EP2396033B1 (es)
JP (1) JP5818693B2 (es)
CN (1) CN102361649A (es)
AU (1) AU2010213966B2 (es)
BR (1) BRPI1008549A2 (es)
CA (1) CA2752205A1 (es)
MX (2) MX2011008497A (es)
RU (2) RU2535970C2 (es)
SG (2) SG173642A1 (es)
WO (1) WO2010093537A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2822895A1 (en) 2004-05-25 2005-12-08 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
CN104278014A (zh) 2006-08-09 2015-01-14 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
EP2396033B1 (en) 2009-02-12 2016-09-28 MedImmune, LLC Influenza hemagglutinin and neuraminidase variants
US8802110B2 (en) 2010-09-21 2014-08-12 Massachusetts Institute Of Technology Influenza treatment and/or characterization, human-adapted HA polypeptides; vaccines
CN108103084B (zh) * 2017-11-21 2020-06-26 浙江迪福润丝生物科技有限公司 区分免疫和感染动物h5亚型禽流感疫苗株及其制备方法和应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992522A (en) * 1973-01-24 1976-11-16 The United States Of America As Represented By The Department Of Health, Education And Welfare Temperature-sensitive recombinant mutant viruses and a process for producing same
US4071618A (en) * 1974-09-03 1978-01-31 Research Foundation For Microbial Diseases Of Osaka University Process for preparing virus disease live vaccines
JPS57136528A (en) * 1981-02-09 1982-08-23 Hayashibara Biochem Lab Inc Preparation of viral vaccine
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
US4634666A (en) 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
US4752473A (en) * 1984-10-12 1988-06-21 The Regents Of The University Of California Expression of glycosylated human influenza hemagglutinin proteins
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
US6001634A (en) * 1989-08-28 1999-12-14 Palese; Peter Recombinant negative strand RNA viruses
US5840520A (en) * 1989-08-28 1998-11-24 Aviron Recombinant negative strand RNA virus expression systems
US5854037A (en) * 1989-08-28 1998-12-29 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand RNA virus expression systems and vaccines
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
ES2247584T3 (es) 1992-04-14 2006-03-01 The Mount Sinai School Of Medicine Of The City University Of New York Virus atenuados por ingenieria genetica.
IL105456A (en) 1992-04-21 1996-12-05 American Home Prod Vaccines of attenuated respiratory syncytial virus
DE69532369T3 (de) 1994-07-18 2010-11-04 Conzelmann, Karl-Klaus, Prof. Dr. Rekombinantes infektiöses nicht-in-Segmente-geteiltes, negativ-Strange-RNS-Virus
WO1996010400A1 (en) * 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
US7153510B1 (en) 1995-05-04 2006-12-26 Yale University Recombinant vesiculoviruses and their uses
US5690937A (en) 1995-06-05 1997-11-25 Aviron Temperature sensitive clustered changed-to-alanine mutants of influenza virus PB2 gene
DE69510207T3 (de) 1995-08-09 2007-02-15 Schweiz. Serum- & Impfinstitut Bern Verfahren zur Herstellung von infektiösen minussträngigen RNA-Viren
AU727923B2 (en) 1995-09-27 2001-01-04 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Production of infectious respiratory syncytial virus from cloned nucleotide sequences
DK0864645T3 (da) 1995-10-31 2005-10-24 Dnavec Research Inc Negativstrenget RNA-virusvektor med autonom replikeringsaktivitet
KR100525687B1 (ko) 1995-11-01 2005-11-25 가부시끼가이샤 디나벡 겡뀨쇼 재조합체 센다이바이러스
US6090391A (en) * 1996-02-23 2000-07-18 Aviron Recombinant tryptophan mutants of influenza
WO1998002530A1 (en) 1996-07-15 1998-01-22 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
EP0932684A2 (en) 1996-09-27 1999-08-04 American Cyanamid Company 3' genomic promoter region and polymerase gene mutations responsible for attenuation in viruses of the order designated mononegavirales
ATE501259T1 (de) 1997-05-23 2011-03-15 Us Of America As Represented By The Secretary Of The Dept Of Health And Human Services Herstellung attenuierter parainfluenza-virus impfstoffe aus klonierten nukleotidsequenzen
JP4434478B2 (ja) 1997-07-11 2010-03-17 イエール ユニバーシティー リエンジニアリングされた外被を有するラブドウイルス
EP1015594A1 (en) 1997-09-19 2000-07-05 American Cyanamid Company Attenuated respiratory syncytial viruses
US6146642A (en) * 1998-09-14 2000-11-14 Mount Sinai School Of Medicine, Of The City University Of New York Recombinant new castle disease virus RNA expression systems and vaccines
EP1035209A1 (en) 1999-03-06 2000-09-13 ARTEMIS Pharmaceuticals GmbH Stable recombinant influenza viruses free of helper viruses
US8715940B2 (en) 1999-04-06 2014-05-06 Wisconsin Alumni Research Foundation Method of making recombinant influenza virus
DK1185615T3 (da) 1999-04-06 2007-11-05 Wisconsin Alumni Res Found Rekombinante influenzavirus til vacciner og genterapi
US6800288B2 (en) 2000-03-02 2004-10-05 Polymun Scientific Immunbiologische Forschung Gmbh Recombinant influenza A viruses
WO2001083794A2 (en) 2000-04-28 2001-11-08 St. Jude Children's Research Hospital Dna transfection system for the generation of infectious influenza virus
ES2327103T3 (es) * 2000-09-25 2009-10-26 Polymun Scientific Immunbiologische Forschung Gmbh Vacuna viva de influenzavirus y procedimiento de fabricacion.
USPP15035P3 (en) * 2001-06-27 2004-07-27 Marko Zaninovich, Inc. Grapevine ‘12-76-71’
KR100600988B1 (ko) * 2002-03-13 2006-07-13 주식회사 엘지생명과학 Ｄｎａ 면역화에서 인플루엔자 ｎｐ 유전자 ｄｎａ를 함께투여하여 면역반응을 증가시키는 방법
US7465456B2 (en) * 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
AU2003231083A1 (en) * 2002-04-26 2003-11-10 Medimmune, Llc Multi plasmid system for the production of influenza virus
WO2005018539A2 (en) * 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
US7037707B2 (en) * 2003-09-04 2006-05-02 St. Jude Children's Research Hospital Method for generating influenza viruses and vaccines
CA2822895A1 (en) 2004-05-25 2005-12-08 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
EP2388340B1 (en) 2004-11-01 2013-04-03 Eiken Kagaku Kabushiki Kaisha Method of detecting H7 avian influenza virus
ES2527503T3 (es) * 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
RU2315101C2 (ru) * 2006-01-10 2008-01-20 ГУ "Научно-исследовательский институт экспериментальной медицины "Российской Академии медицинских наук (ГУ НИИЭМ РАМН) Вакцинный штамм вируса гриппа а/17/калифорния/ 04/6 (н3n2) и донор аттенуации а/ленинград/134/17/к7/57 (н2n2) для его получения
CN104278014A (zh) * 2006-08-09 2015-01-14 米迪缪尼有限公司 流感血凝素和神经氨酸酶变体
US8084594B2 (en) * 2007-07-13 2011-12-27 The United States Of America As Represented By The Secretary Of Agriculture H2N3 influenza A viruses and methods of use
EP2396033B1 (en) 2009-02-12 2016-09-28 MedImmune, LLC Influenza hemagglutinin and neuraminidase variants

Also Published As

Publication number Publication date
US20100330118A1 (en) 2010-12-30
AU2010213966A1 (en) 2011-09-01
CA2752205A1 (en) 2010-08-19
JP2012517239A (ja) 2012-08-02
BRPI1008549A2 (pt) 2016-03-15
RU2014140731A (ru) 2016-04-27
US8613935B2 (en) 2013-12-24
EP2396033A4 (en) 2013-10-23
SG173642A1 (en) 2011-09-29
SG2014010185A (en) 2014-06-27
AU2010213966B2 (en) 2015-01-22
WO2010093537A3 (en) 2010-10-07
CN102361649A (zh) 2012-02-22
RU2011137404A (ru) 2013-03-20
EP2396033A2 (en) 2011-12-21
US20140079726A1 (en) 2014-03-20
JP5818693B2 (ja) 2015-11-18
MX2011008497A (es) 2011-12-16
WO2010093537A2 (en) 2010-08-19
EP2396033B1 (en) 2016-09-28
RU2535970C2 (ru) 2014-12-20
US9119812B2 (en) 2015-09-01

Similar Documents

Publication Publication Date Title
MX2011000437A (es) Variantes de hemaglutinina y neuramnidasa de influenza.
MX2012000123A (es) Variantes de hemaglutinina de la influenza porcina.
IL231547B (en) Polypeptide of the chimeric hemagglutinin (ha) from an influenza virus, an immune composition containing it and its uses
WO2008021959A3 (en) Influenza hemagglutinin and neuraminidase variants
MX2021001053A (es) Vacunas contra virus de la influenza y sus usos.
WO2006098901A3 (en) Influenza hemagglutinin and neuraminidase variants
IL210215A0 (en) Influenza virus-like particles (vlps) comprising hemagglutinin
WO2012024621A3 (en) Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
WO2005116260A3 (en) Influenza hemagglutinin and neuraminidase variants
PH12015501482B1 (en) Nasal influenza vaccine composition
MX2010008799A (es) Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
WO2008112017A3 (en) Avian influenza vaccine
MX2012009581A (es) Vacunas para su uso en la profilaxis y tratamiento de la enfermedad del virus de influenza.
AP2008004625A0 (en) Avian influenza viruses, vaccines, compositions, formulations, and methods
IL213189A0 (en) Recombinant avian influenza vaccine and uses thereof
WO2008147496A3 (en) Neuraminidase-deficient live influenza vaccines
ZA200905952B (en) Lyophilized preparation comprising influenza vaccine,and method for preparation thereof
IL224022B (en) Thermally stable influenza vaccine
NZ606087A (en) Influenza vaccine
EP2486791A4 (en) PROTEIN VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA VIRUS FROM TRANSGENIC PLANTS AND PREPARATION METHOD THEREOF
EA201290897A1 (ru) Вакцины для пандемического гриппа
MX343411B (es) Variantes de hemaglutinina y neuraminidasa de influenza.
EP2117589A4 (en) FLAVIVIRUS VACCINE VECTOR AGAINST INFLUENZA VIRUS
EA201590860A1 (ru) Варианты гемагглютинина и нейраминидазы вируса свиного гриппа
EP2716752A4 (en) RECOMBINANT DOG INFLUENZA VIRUS, MANUFACTURING METHOD AND APPLICATION THEREOF